TaiMed Biologics Inc. (TPEX: 4147)

TaiMed Biologics Revenue

TaiMed Biologics had revenue of 138.51M TWD in the quarter ending September 30, 2024, a decrease of -12.09%. This brings the company's revenue in the last twelve months to 622.61M, down -5.67% year-over-year. In the year 2023, TaiMed Biologics had annual revenue of 491.78M, down -12.65%.

• Revenue (ttm): 622.61M
• Revenue Growth: -5.67%
• P/S Ratio: 37.32
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 24.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	491.78M	-71.23M	-12.65%
Dec 31, 2022	563.01M	149.57M	36.18%
Dec 31, 2021	413.44M	-309.04M	-42.78%
Dec 31, 2020	722.49M	17.98M	2.55%
Dec 31, 2019	704.50M	463.46M	192.28%